Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
228
datasets available to search
ShareScore release 0.9.0
Dataset results
228 results for “Valsartan”
Figure 1 from: Logoyda L (2021) Novel HPLC-UV method for simultaneous determination of valsartan and atenolol in fixed dosage form; Study of green profile assessment. Pharmacia 68(1): 43-51. https://doi.org/10.3897/pharmacia.68.e53631
Figure 1 Chemical structure of valsartan.
Figure 2 from: Logoyda L (2021) Novel HPLC-UV method for simultaneous determination of valsartan and atenolol in fixed dosage form; Study of green profile assessment. Pharmacia 68(1): 43-51. https://doi.org/10.3897/pharmacia.68.e53631
Figure 2 Chemical structure of atenolol.
Figure 4 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 4 Absorption spectra of BPB and valsartan with BPB in different solvents.
Figure 6 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 6 Absorption spectra of MR and valsartan with MR in different solvents.
Figure 2 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 2 Absorption spectra of valsartan with BPB
Figure 3 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 3 Absorption spectra of valsartan with MR.
Figure 1 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 1 Chemical structure of valsartan.
Figure 10 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 10 Calibration curve for the determination of valsartan with BPB.
Figure 11 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559
Figure 11 Calibration curve for the determination of valsartan with MR.
Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
ClinicalTrials.gov study NCT00170989. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertens
ClinicalTrials.gov study NCT01878201. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
ClinicalTrials.gov study NCT00171093. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months
ClinicalTrials.gov study NCT00487123. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
ClinicalTrials.gov study NCT00190580. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The DDI Study of SP2086 and Valsartan
ClinicalTrials.gov study NCT02817217. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy
ClinicalTrials.gov study NCT00546754. IPD Sharing: NO. Countries: 0. Publications: 0.
Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.
ClinicalTrials.gov study NCT00416468. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Is Sacubitril-valsartan Superior to Dapagliflozin in Improving Myocardial Function Performance
ClinicalTrials.gov study NCT06090487. IPD Sharing: NO. Countries: 1. Publications: 0.
Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects.
ClinicalTrials.gov study NCT00416728. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage
ClinicalTrials.gov study NCT00687206. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.